Markets.com Logo

LLY

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    599.9959$
  • Previous Close
    619.9924$
  • 52 Week Change
    340.15$
  • Day Range
    -20.00$
  • 52 Week High/Low
    538.3723$ - 878.5214$
  • Dividend Per Share
    0.0146
  • Market cap
    206 794 M$
  • EPS
    3.34
  • Beta
    --
  • Volume
    --

About

LLY.BE represents the shares of Eli Lilly and Company (LLY) traded on the Euronext Brussels stock exchange. It is the same company as LLY which is listed on the NYSE, but trading on a different exchange. Euronext Brussels typically displays prices in Euros. Therefore, if you see LLY.BE, it indicates Eli Lilly shares being bought and sold in the European market, specifically in Brussels.
XAU/USD Forecast: Will Gold Rebound or Continue Pullback Amid Oil Surge and Geopolitical Risks?

XAU/USD Forecast: Will Gold Rebound or Continue Pullback Amid Oil Surge and Geopolitical Risks?

Ghko B|--
Nvidia (NVDA) Q1 Earnings 2027: Will AI Growth Drive NVDA Stock Prices Further?

Nvidia (NVDA) Q1 Earnings 2027: Will AI Growth Drive NVDA Stock Prices Further?

Ghko B|--

AMD's Share Price Surges to Record Highs Driven by Server CPU Momentum

Noah Lee|--

Gold Volatility: Is a Structural Shift Underway? An In-depth Analysis

Noah Lee|--

S&P 500's Record Rally Continues: Nomura Strategist Flags Two Key Exit Signals

Liam James|--
Crypto Market Analysis: Why Does South Korea Now Account for 30% of Global Crypto Trading Volume?

Crypto Market Analysis: Why Does South Korea Now Account for 30% of Global Crypto Trading Volume?

Ghko B|--
Forex market analysis: NZD/USD approaches 0.5900, what could influence its next moves?

Forex market analysis: NZD/USD approaches 0.5900, what could influence its next moves?

Frances Wang|--

Factors

Drug Pipeline Progress: Positive clinical trial results and regulatory approvals for new drugs typically drive the stock price up. Conversely, setbacks or failures in the pipeline can lead to price declines. Pharmaceutical Market Trends: Changes in healthcare spending, demographics, and disease prevalence can affect demand for Eli Lilly's products and impact its stock price. Competition: The entry of generic versions of Eli Lilly's drugs or the development of competing innovative therapies by other companies can put pressure on sales and reduce the stock price. Economic Conditions: General economic downturns or recessions can affect healthcare spending and pharmaceutical sales, potentially impacting Eli Lilly's revenue and stock price. Regulatory Environment: Changes in drug pricing regulations, patent laws, or healthcare policies can significantly impact Eli Lilly's profitability and stock value. Company Performance: Revenue growth, earnings per share, and profit margins are key indicators of Eli Lilly's financial health, which directly influences investor confidence and stock price.

People Also Watch

Latest news

Gold Price Today, April 20: Gold (XAUUSD) Slumps Below $4,800 on Renewed Strait of Hormuz Tensions

Gold Price Today, April 20: Gold (XAUUSD) Slumps Below $4,800 on Renewed Strait of Hormuz Tensions

Ghko B|--
Tesla (TSLA) Stock News: Tesla Faces $43.9 Billion Free Cash Flow Swing As 2026 Outlook Turns Negative

Tesla (TSLA) Stock News: Tesla Faces $43.9 Billion Free Cash Flow Swing As 2026 Outlook Turns Negative

Ghko B|--

Market and Economic Roundup: Geopolitical Shifts and Financial Performance Insights

Ava Grace|--

Latest Education Articles

CFD Rollover: What It Is, How It Works, and How Traders Can Manage It

CFD Rollover: What It Is, How It Works, and How Traders Can Manage It

Julian Parker|--
Natural Gas vs. Crude Oil Trading: What CFD Traders Need to Understand

Natural Gas vs. Crude Oil Trading: What CFD Traders Need to Understand

Julian Parker|--
Bitcoin vs. Ethereum in 2026: Key Differences, Investment Cases, and What to Watch Next

Bitcoin vs. Ethereum in 2026: Key Differences, Investment Cases, and What to Watch Next

Julian Parker|--
Recommended Topics